ApprovalTrail

Approval · Notice of Compliance 9461 · 2008

MIRCERA (VIALS): Notice of Compliance 9461

Issued March 31, 2008

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
9461
Date
March 31, 2008
Company
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)
Therapeutic class
Erythropoiesis stimulating agent

Products in this notice

BrandDINStatus today
MIRCERA (VIALS)02307995Cancelled Pre Market
MIRCERA (VIALS)02308002Cancelled Pre Market
MIRCERA (VIALS)02308010Cancelled Pre Market
MIRCERA (VIALS)02308029Cancelled Pre Market
MIRCERA (VIALS)02308037Cancelled Pre Market
MIRCERA (VIALS)02308045Cancelled Pre Market
MIRCERA (VIALS)02308053Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308061Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308088Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308096Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308118Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308126Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308134Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308142Cancelled Pre Market
MIRCERA (PRE-FILLED SYRINGE)02308150Cancelled Pre Market

Medicinal ingredients